Study of Tinostamustine for Adjuvant Treatment of Glioblastoma

Clinical trial NCT05432375 · COMPLETED

Trial details

NCT number: NCT05432375
Sponsor: Mundipharma Research Limited
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Glioblastoma Multiforme

Start date: 2022-07-01
Primary completion: 2024-11-10
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.